Celgene (Nasdaq: CELG) is a biotechnology company providing treatment products for cancer and inflammatory-diseases.
Recent Mentions on Fool.com
- Celgene's Narrow Beat on Second-Quarter Earnings Fails to Impress Investors; Shares Fall
- Yellen Hates Biotech Stocks! Should You?
- The 4 Most Important S&P 500 Stocks of the Past 16 Years
- Better Stock Today Challenge: Celgene vs. Facebook
- Better Stock Today Challenge: Energy Transfer Partners vs. Celgene